Amgen Bangladesh is a subsidiary of Amgen Inc., one of the world's leading biotechnology companies. The company is dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. It focuses on areas of high unmet medical need, leveraging expertise in biology, chemical engineering, and a variety of other scientific disciplines to develop medicines that can help millions of patients around the world.

George Rathmann

Amgen Bangladesh

Solbosch provides a variety of medical and paramedical specialties. It is equipped with a viral air purifier.

Solbosch

Nobias Therapeutics is a clinical-stage company developing novel small-molecule therapeutics for rare diseases, focusing initially on pediatric indications and expanding to adults and non-rare indications. This description is self-described.

Nobias Therapeutics

Prenosis develops precision medicine tools and implements them in real time for acute care settings, focusing on personalizing healthcare based on individual biology. They leverage their Immunix precision medicine platform and have created the FDA authorized Sepsis ImmunoScore.

Metric
Company Name	Amgen Bangladesh	Solbosch	Nobias Therapeutics	Prenosis
Symbol
MSH ID	COM:AMGENBD	BE:SOLBOSCH	COM:NOBIASTX	COM:PRENOSIS
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Biotechnology	Healthcare	Biotechnology	Biotechnology
Country		BE	US	US
Stage			Series A	Grant
Employee Count	10.00K
Website	amgenbd.com	solbosch.be	nobiastx.com	prenosis.com
LinkedIn		le-solbosch	nobias-therapeutics	prenosis
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	270	1.15K
Web Traffic Growth	-0.35	46.92
Valuation
Raised Capital	3.75M	4.80M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

AMGE

COM:AMGENBD

Amgen Bangladesh

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue